Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition

This study aimed to develop a computed tomography (CT)-based radiomics model capable of precisely predicting hyperprogression and pseudoprogression (PP) in patients with non-small cell lung cancer (NSCLC) treated with immunotherapy. We retrospectively analyzed 105 patients with NSCLC, from three ins...

Description complète

Détails bibliographiques

Auteurs principaux:	Yikun Li, Peiliang Wang, Junhao Xu, Xiaonan Shi, Tianwen Yin, Feifei Teng
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2024-12-01
Collection:	OncoImmunology
Sujets:	Computed tomography hyperprogression immunotherapy non-small cell lung cancer pseudoprogression radiomics
Accès en ligne:	https://www.tandfonline.com/doi/10.1080/2162402X.2024.2312628
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!